Close
4

Suanfarma Suanfarma

X

CAS 1464-53-5 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 1464-53-5
Also known as: Diepoxybutane, 1,3-butadiene diepoxide, 1464-53-5, Butadiene diepoxide, Butadiene dioxide, Dioxybutadiene
Molecular Formula
C4H6O2
Molecular Weight
86.09  g/mol
InChI Key
ZFIVKAOQEXOYFY-UHFFFAOYSA-N

Diepoxybutane is a colorless, highly flammable, liquid cyclic ether. Diepoxybutane is primarily used for research purposes, but is also used as a curing agent for polymer resins and as a cross-linking agent for making synthetic textile fibers. Exposure to this substance can severely irritate and burn the eyes and skin and can cause liver damage. Diepoxybutane is reasonably anticipated to be a human carcinogen based on evidence of carcinogenicity in experimental animals. (NCI05)
1 2D Structure

CAS 1464-53-5

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-(oxiran-2-yl)oxirane
2.1.2 InChI
InChI=1S/C4H6O2/c1-3(5-1)4-2-6-4/h3-4H,1-2H2
2.1.3 InChI Key
ZFIVKAOQEXOYFY-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1C(O1)C2CO2
2.2 Synonyms
2.2.1 MeSH Synonyms

1. 1,2,3,4-diepoxybutane

2. 1,2-3,4-diepoxybutane

3. Butadiene Bisoxide

4. Butadiene Diepoxide

5. Butadiene Dioxide

6. Diepoxybutane

7. Diepoxybutane, Meso-

8. Erythritol Anhydride

9. Erythritol Anhydride, ((r*,r*)-(+-))-isomer

10. Erythritol Anhydride, (r*,s*)-isomer

11. Erythritol Anhydride, (r-(r*,r*))-isomer

12. Erythritol Anhydride, (s-(r*,r*))-isomer

13. Meso-diepoxybutane

2.2.2 Depositor-Supplied Synonyms

1. Diepoxybutane

2. 1,3-butadiene Diepoxide

3. 1464-53-5

4. Butadiene Diepoxide

5. Butadiene Dioxide

6. Dioxybutadiene

7. Bioxirane

8. Butane Diepoxide

9. 1,2:3,4-diepoxybutane

10. Bioxiran

11. 2-(oxiran-2-yl)oxirane

12. Butadiendioxyd

13. 1,2:3,4-butadiene Diepoxide

14. Butane, 1,2:3,4-diepoxy-

15. 1,2,3,4-diepoxybutane

16. Rcra Waste Number U085

17. 1,1'-bi(ethylene Oxide)

18. 1,1'-bi[ethylene Oxide]

19. Cb 1181

20. Nsc 629

21. Threitol, 1,2:3,4-dianhydro-

22. R 181

23. Ent-26592

24. M 8838

25. D,l-diepoxybutane

26. Chebi:23704

27. D,l-1,2:3,4-diepoxybutane

28. 298-18-0

29. Unii-60ob65ynab

30. Butadiendioxyd [german]

31. Ccris 234

32. Butane,2:3,4-diepoxy-

33. Hsdb 4046

34. Einecs 215-979-1

35. Rcra Waste No. U085

36. Wln: T3otj B- Bt3otj

37. Brn 0079833

38. 1,2,3,4-diepoxybutane Dl

39. Ai3-26592

40. 1,4-diepoxybutane

41. 2,4-diepoxybutane

42. 2,2'-bioxirane, (r*,r*)-(.+/-.)-

43. 1,3,4-diepoxybutane

44. 60ob65ynab

45. 1,2:3,4-dianhydrothreitol

46. Threitol,2:3,4-dianhydro-

47. 5-19-01-00185 (beilstein Handbook Reference)

48. Nsc629

49. Chembl1964283

50. Dtxsid0041307

51. 1,3-butadiene Diepoxide, 97%

52. Zfivkaoqexoyfy-uhfffaoysa-

53. Nsc-629

54. 5-(dimetnmet)furfuryl Alcohol Hcl

55. (a+/-)-1,2;3,4-diepoxy-butane

56. Akos017342854

57. 2,2 Inverted Exclamation Marka-bioxirane

58. Nci60_009412

59. 1,3-butadiene Diepoxide, Analytical Standard

60. B0234

61. Cs-0377906

62. D3410

63. Ft-0606590

64. Butane, 1,2:3,4-diepoxy-, (.+/-.)-

65. J-503880

66. J-640017

67. J-800012

68. Q5274970

69. Erythrithol Anhydride (old Name); 1,3-butadiene Diepoxide

2.3 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 86.09 g/mol
Molecular Formula C4H6O2
XLogP3-0.5
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count1
Exact Mass86.036779430 g/mol
Monoisotopic Mass86.036779430 g/mol
Topological Polar Surface Area25.1 Ų
Heavy Atom Count6
Formal Charge0
Complexity61.9
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count2
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Carcinogens

Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)


Cross-Linking Reagents

Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)


Mutagens

Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)


4.2 Absorption, Distribution and Excretion

Experiments were carried out to study the uptake, retention, routes of elimination, and identification of butadiene metabolites in rats and mice. Male Sprague-Dawley rats and male B6C3F1 mice were administered (14)C labeled butadiene by inhalation at 0.14 to 13000 microg/l air. The percentage of (14)C absorbed and retained at 6 hours after exposure was 1.5 to 17 in rats and 4 to 20 in mice. Major routes of elimination were exhalation and urine discharge, accounting for 75 to 85% of the total (14)C. About 12% of (14)C remained in the carcass 65 hours after the exposure. At the 13 microg/l dose, all (14)C was accounted for as metabolites. At the lowest butadiene concentrations (14)C in urine and exhaled air represented 40 and 20% of the total (14)C eliminated. At the highest butadiene concentration (14)C in urine decreased to 8 % of total (14)C eliminated or retained in carcass. More than 90% of (14)C in blood samples consisted of butadiene metabolites, of which 60 to 80 % was nonvolatile material. The amount of metabolites increased with the concentration of inhaled butadiene, but the increase was not proportional to the uptake. At 130 and 1800 microg/l butadiene mice had about twofold higher amount of 1,2-epoxy-3-butene than rats. The quantities of butadiene-diepoxide in rats subjected to the same exposure levels of butadiene were 0.1 and 1 nmol/ml blood after 6 hours. /Butadiene/

PMID:3726881 Bond JA et al; Toxicol Appl Pharmacol 84 (3): 617-627 (1986)


4.3 Metabolism/Metabolites

Experiments were carried out to study the uptake, retention, routes of elimination, and identification of butadiene metabolites in rats and mice. Male Sprague-Dawley rats and male B6C3F1 mice were administered (14)C labeled butadiene by inhalation at 0.14 to 13000 microg/l air. The percentage of (14)C absorbed and retained at 6 hours after exposure was 1.5 to 17 in rats and 4 to 20 in mice. Major routes of elimination were exhalation and urine discharge, accounting for 75 to 85% of the total (14)C. About 12% of (14)C remained in the carcass 65 hours after the exposure. At the 13 microg/l dose, all (14)C was accounted for as metabolites. At the lowest butadiene concentrations (14)C in urine and exhaled air represented 40 and 20% of the total (14)C eliminated. At the highest butadiene concentration (14)C in urine decreased to 8 % of total (14)C eliminated or retained in carcass. More than 90% of (14)C in blood samples consisted of butadiene metabolites, of which 60 to 80 % was nonvolatile material. The amount of metabolites increased with the concentration of inhaled butadiene, but the increase was not proportional to the uptake. At 130 and 1800 microg/l butadiene mice had about twofold higher amount of 1,2-epoxy-3-butene than rats. The quantities of butadiene-diepoxide in rats subjected to the same exposure levels of butadiene were 0.1 and 1 nmol/ml blood after 6 hours. /Butadiene/

PMID:3726881 Bond JA et al; Toxicol Appl Pharmacol 84 (3): 617-627 (1986)


Diepoxybutane (DEB) is a known human metabolite of butadiene_monoxide.

S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY